Janssen Infectious Diseases

GPTKB entity

Properties (60)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:aimsTo improve_global_health
gptkbp:collaboratesWith government agencies
academic institutions
gptkbp:conducts clinical research
gptkbp:develops vaccines
antiviral therapies
gptkbp:employs researchers
scientists
gptkbp:focusesOn infectious diseases
gptkbp:hasCollaboratedWith gptkb:CDC
WHO
gptkbp:hasDeveloped gptkb:COVID-19_vaccine
HIV treatment
tuberculosis treatment
antibiotic treatments
gptkbp:hasEstablished research collaborations
gptkbp:hasHistoricalSignificance gptkb:Beerse,_Belgium
gptkbp:hasLocalCuisine various countries
gptkbp:hasParticipatedIn over 150 countries
gptkbp:hasPartnershipsWith non-profit organizations
healthcare_providers
gptkbp:hasResearchInterest gptkb:COVID-19
HIV
tuberculosis
gptkbp:hasResidence government grants
private investors
https://www.w3.org/2000/01/rdf-schema#label Janssen Infectious Diseases
gptkbp:isActiveIn vaccine distribution
clinical research trials
gptkbp:isDedicatedTo patient care
advancing medical science
gptkbp:isEngagedIn community outreach
biomedical research
therapeutic development
gptkbp:isFocusedOn disease prevention
vaccine development
global health challenges
patient-centered solutions
gptkbp:isInvolvedIn educational programs
public health initiatives
global health security
vaccine research
infectious disease prevention
healthcare_innovation
healthcare_partnerships
gptkbp:isKnownFor research and development
collaborative research efforts
innovative treatments
clinical excellence
gptkbp:isPartOf gptkb:Johnson_&_Johnson's_pharmaceutical_segment
biopharmaceutical industry
Johnson_&_Johnson's_global_health_strategy
Johnson_&_Johnson's_commitment_to_health
gptkbp:isRecognizedFor scientific contributions
innovation in healthcare
public health impact
gptkbp:offers clinical trials
gptkbp:partOf gptkb:Johnson_&_Johnson
gptkbp:wasFoundedIn 2009